Home›Screener›ALLO›Profile

C

55/100

Allogene Therapeutics

ALLOCell Therapy

← Signals View

📋

Analyst Summary

✓ VERIFIED2026-04-11

Allogene Therapeutics (ALLO) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov^[3], including 2 Phase 2^[1], 4 Phase 1^[2].

ALLO has 3 Form 4 insider filings recorded at the SEC in the past 30 days^[4].

Sources

ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
SEC EDGAR · 0001737287 (2026-04-11) ↗

🔬

Clinical Trials

6

NCT04093596Relapsed/Refractory Multiple Myeloma

clinicaltrials_gov · Retrieved 2026-04-11

NCT04416984Relapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT04696731Advanced/Metastatic Clear Cell Renal Cell Carcinoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT06500273Large B-cell Lymphoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT06925685Hematologic Malignancies, Solid Tumors

clinicaltrials_gov · Retrieved 2026-04-11

NCT07085104Systemic Lupus Erythematosus (With and Without Nephritis), Idiopathic Inflammatory Myopathy, Systemic Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

👤

Insider Activity

1

3 filings

sec_edgar · Retrieved 2026-04-11

Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.

Score Breakdown

Score Trend

2026-04-132026-06-02

Signal Summary

PDUFA Dates0

Insider Filings1

Clinical Trials3

Sector Peers (Cell Therapy)

ATRAAtara Biotherapeutics

A

VORVor Biopharma

C

IOVAIovance Biotherapeutics

C

FATEFate Therapeutics

C

MBIOMustang Bio

Data Provenance

cik1 verified

clinical trial6 verified

insider buy1 verified

trial count3 verified

Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR